info@alltox.it| +39.0323.586239
  • HOME
  • ALLTOX
    • WHO WE ARE
    • AIMS
    • BACKGROUND
  • OUR SERVICES
    • IN VITRO SENSITIZATION ASSAYS
    • CYTOKINE RELEASE
    • SKIN ABSORPTION
    • NICKEL RELEASE
    • LLNA
    • LATEX ALLERGY
    • IN VITRO INHIBITION OF BASOPHIL DEGRANULATION
    • IN VITRO INHIBITION OF ALLERGIC SENSITIZATION
    • ATOPIC DERMATITIS
    • EXPERT REPORT AND ETHICAL CLEARANCE
    • HISTAMINE INTOLERANCE
  • BIBLIOGRAPHY
  • LINKS
  • CONTACTS AND ORDERS
  • enEnglish
    • itItaliano

Blog Post

AUGUST 2018

Posted By : admin
Comments : Off

ALLTOX funded research is published: “Multiple Epitope Presentation and Surface Density Control Enabled by Chemoselective Immobilization Lead to Enhanced Performance in IgE-binding Fingerprinting on Peptide Microarrays”. Tandem peptide technology provides an approximately twofold increased IgE binding capacity with respect to the linear and branched peptides, in the context of a Multiple Epitope Presentation (MPE) setting

Anal Chim Acta. 2017 Aug 29;983:189-197. doi: 10.1016/j.aca.2017.06.027

About the Author

Social Share

  • google-share

Dove siamo

ALLTOX è un'attività del Laboratorio di Allergologia Cellulare e Molecolare diretto dal Dr. Samuele Burastero, presso l'Istituto Scientifico Ospedale San Raffaele,   edificio DIBIT-1, via Olgettina, 58, 20132 Milano - LACM

Alltox
- In vitro determination of allergenicity of xenobiotics 
- All-in-one molecular diagnosis of allergies 
- Histamine intolerance

Admin tools
enter admin area

developed by Flylab Creative Media
Copyright 2013 | Alltox
Utilizziamo i cookie per essere sicuri che tu possa avere la migliore esperienza sul nostro sito. Se continui ad utilizzare questo sito noi assumiamo che tu ne sia felice.Ok